Vaccine
-
Multicenter Study Clinical Trial
Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.
The aim of this study was to determine the immunogenicity and reactogenicity of HPV vaccine in immunocompromised children. ⋯ NCT02263703 (ClinicalTrials.gov).